Michael Nagel - Jun 30, 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Role
Director
Signature
/s/ Daniel Clark, attorney-in-fact
Stock symbol
KRBP
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
4
Date filed
7/5/2022, 04:02 PM
Next filing
Oct 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Stock Option (Right to Buy) Award $0 +184K +3478.59% $0.00 189K Jun 30, 2022 Common Stock 184K $0.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest according to the following schedule: (a) 50% of the options vest on June 30, 2022, (b) 25% of the options vest on September 30, 2022, and (c) the remaining 25% of the options vest on December 31, 2022.

Remarks:

Exhibit 24.1 - Power of Attorney